Leonard M. Greenstein, Chief Financial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 5,000 shares at $14.56 ($73K) on 2023-01-19, disclosed to the SEC on 2023-01-20.
Open-market sale of $73k TARS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TARS | SELL | 2023-03-21 | $8K | — | Filing → |
| TARS | SELL | 2023-03-17 | $71K | — | Filing → |
| TARS | SELL | 2023-02-17 | $76K | — | Filing → |